Contract analysis

I. EXECUTIVE SUMMARY This Irreparable Harm Evidence Compilation consolidates all factual evidence, documentary sources, deposition testimony, and financial data supporting a finding of irreparable harm caused by Lumicore Technologies, Inc.'s ("Lumicore") infringement of U.S. Patent Nos. 10,234,847 (the "'847 Patent"), 10,891,193 (the "'193 Patent"), 9,678,562 (the "'562 Patent"), and 11,402,015 (the "'015 Patent") (c

II. LEGAL FRAMEWORK A. The *Cascade Holdings* Four-Factor Test In Northgate Group v. MercExchange, L.L.C., 547 U.S. 388 (2006), the Supreme Court held that the traditional four-factor test for permanent injunctive relief applies with equal force in patent cases. Under that test, a plaintiff seeking a permanent injunction must demonstrate: (1) that it has suffered an irreparable injury; (2) that remedies available at

III. EVIDENCE OF DIRECT COMPETITION A. Market Overlap Between OWS and Lumicore The most foundational element of OWS's irreparable harm showing is the undisputed fact that OWS and Lumicore are direct competitors in the same product market: silicon-photonics transceiver modules for hyperscale data centers. Optiwave Semiconductor Corp. ("OWS"). OWS is the third-largest U.S. supplier of silicon-photonics transceiver modu

IV. EVIDENCE OF PRICE EROSION A. Overview of ASP Decline One of the most significant and measurable forms of irreparable harm suffered by OWS is the erosion of average selling prices ("ASPs") in the transceiver module market following Lumicore's entry with its infringing products. The evidence compiled to date demonstrates that the ASP of 400G-ZR transceiver modules — the product segment where competition between OWS

V. EVIDENCE OF CUSTOMER DIVERSION A. Head-to-Head Customer Losses Beyond price erosion, OWS has suffered direct, quantifiable customer diversion as a result of Lumicore's infringement. The evidence compiled to date identifies specific instances in which OWS lost customers or customer orders to Lumicore's accused products. This customer diversion is distinct from — and additive to — the price erosion harm discussed in

VI. EVIDENCE OF LOSS OF DESIGN-IN OPPORTUNITIES A. Significance of Design-In Wins in the Transceiver Market In the silicon-photonics transceiver industry, the single most consequential competitive event is the "design-in" win — the point at which a hyperscale customer selects a supplier's transceiver module for integration into a new data-center architecture, platform, or deployment generation. Design-in wins are the

VII. EVIDENCE OF REPUTATIONAL AND COMPETITIVE-POSITION HARM A. Erosion of Market Leadership Position OWS's position as the third-largest U.S. supplier of silicon-photonics transceiver modules is a hard-won competitive asset built over years of investment in technology development, customer relationships, and manufacturing capability. Lumicore's rapid growth using infringing technology directly threatens to displace O

VIII. EVIDENCE THAT MONETARY DAMAGES ARE INADEQUATE A. Difficulty of Quantifying Ongoing Harm The evidence compiled in Sections IV through VII demonstrates that OWS's harm from Lumicore's infringement is not a discrete, one-time injury that can be precisely calculated and compensated through a monetary award. Rather, the harm is ongoing, cumulative, and partially unquantifiable, characteristics that the Federal Circu